JournalTOCs

Expert Opinion on Therapeutic Patents
Journal Prestige (SJR): 0.926

Citation Impact (citeScore): 3
Number of Followers: 9

Hybrid journal (It can contain Open Access articles)
ISSN (Print) 1354-3776 - ISSN (Online) 1744-7674
Published by Taylor and Francis

[2648 journals]

Butyrylcholinesterase inhibitors as potential anti-Alzheimer’s agents:
an updated patent review (2018-present)
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: José G. Fernández-Bolaños, Óscar López
  Pages: 1 - 20
  Abstract: .
  
  Citation: Expert Opinion on Therapeutic Patents
  PubDate: 2022-06-23T07:22:24Z
  DOI: 10.1080/13543776.2022.2083956
An updated patent review on monoamine oxidase (MAO) inhibitors
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Paolo Guglielmi, Simone Carradori, Ilaria D’Agostino, Cristina Campestre, Jacobus P. Petzer
  Pages: 1 - 35
  Abstract: .
  
  Citation: Expert Opinion on Therapeutic Patents
  PubDate: 2022-06-09T03:14:26Z
  DOI: 10.1080/13543776.2022.2083501
Anticancer carbonic anhydrase inhibitors: a patent and literature update
2018-2022
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Sridhar Goud Nerella, Priti Singh, Mohammed Arifuddin, Claudiu T Supuran
  Pages: 1 - 15
  Abstract: .
  
  Citation: Expert Opinion on Therapeutic Patents
  PubDate: 2022-06-02T07:55:25Z
  DOI: 10.1080/13543776.2022.2083502
A patent review of anticancer CDK2 inhibitors (2017–present)
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Mohamed A. Said, Mohamed A. Abdelrahman, Mohammed A.S. Abourehab, Mohamed Fares, Wagdy M. Eldehna
  Pages: 1 - 14
  Abstract: .
  
  Citation: Expert Opinion on Therapeutic Patents
  PubDate: 2022-05-26T08:00:34Z
  DOI: 10.1080/13543776.2022.2078193
P2X receptor antagonists and their potential as therapeutics: a patent
review (2010–2021)
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Chianna Dane, Leanne Stokes, William T Jorgensen
  Pages: 1 - 22
  Abstract: .
  
  Citation: Expert Opinion on Therapeutic Patents
  PubDate: 2022-05-11T01:09:40Z
  DOI: 10.1080/13543776.2022.2069010
Carbon-11 patents (2012–2022): synthetic methodologies and novel
radiotracers for PET imaging
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Sridhar Goud Nerella, Priti Singh, Sanam Tulja
  Pages: 1 - 15
  Abstract: .
  
  Citation: Expert Opinion on Therapeutic Patents
  PubDate: 2022-04-28T07:49:34Z
  DOI: 10.1080/13543776.2022.2070003
Anti-viral activity of thiazole derivatives: an updated patent review
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Thoraya A. Farghaly, Amani M. R. Alsaedi, Noof A. Alenazi, Marwa F. Harras
  Pages: 1 - 25
  Abstract: .
  
  Citation: Expert Opinion on Therapeutic Patents
  PubDate: 2022-04-27T07:00:49Z
  DOI: 10.1080/13543776.2022.2067477
ATP-citrate lyase (ACLY) inhibitors as therapeutic agents: a patenting
perspective
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Carlotta Granchi
  Pages: 1 - 12
  Abstract: .
  
  Citation: Expert Opinion on Therapeutic Patents
  PubDate: 2022-04-25T06:20:59Z
  DOI: 10.1080/13543776.2022.2067478
Nucleotide pyrophosphatase/phosphodiesterases (NPPs) including NPP1 and
NPP2/ ATX as important drug targets: A patent review (2015-2020)
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Sehrish Bano, Mariya Al-Rashida, Rima D Alharthy, Imtiaz Ali Khan, Jamshed Iqbal
  Pages: 1 - 9
  Abstract: .
  
  Citation: Expert Opinion on Therapeutic Patents
  PubDate: 2022-04-12T07:01:29Z
  DOI: 10.1080/13543776.2022.2058874
A patent review of ubiquitin-specific protease 7 (USP7) inhibitors
(2014-present)
- Free pre-print version: Loading...
  Rate this result: What is this?
  
  Please help us test our new pre-print finding feature by giving the pre-print link a rating.
  A 5 star rating indicates the linked pre-print has the exact same content as the published article.
  
  Authors: Peng Li, Ying Liu, Hong-Min Liu
  Pages: 1 - 15
  Abstract: .
  
  Citation: Expert Opinion on Therapeutic Patents
  PubDate: 2022-03-31T12:21:15Z
  DOI: 10.1080/13543776.2022.2058873